Xerox Holdings Corporation (XRX)

23.38
0.37 1.56
NYSE
Prev Close 23.75
Open 23.50
Day Low/High 23.18 / 23.60
52 Wk Low/High 14.22 / 38.69
Volume 2.43M
Exchange NYSE
Shares Outstanding 191.95B
Market Cap 4.50B
P/E Ratio 12.77
Div & Yield N.A. (N.A)

Latest News

Halfway Home and This Portfolio of Lovable Losers Keeps Delivering

Halfway Home and This Portfolio of Lovable Losers Keeps Delivering

The 2021 Tax Loss Selling Recovery Portfolio didn't do much in April but is soundly beating the market six months after inception.

Bearish Bets: 2 NYSE Stocks You Should Consider Shorting This Week

Bearish Bets: 2 NYSE Stocks You Should Consider Shorting This Week

These names are displaying both quantitative and technical deterioration.

Smaller Value Stocks Take Their Lumps

Smaller Value Stocks Take Their Lumps

Among the names that felt pain were NL Industries, Fossil Group and Manchester United.

It's Tempting to Quit This Portfolio While I'm Waaaay Ahead, but I Won't

It's Tempting to Quit This Portfolio While I'm Waaaay Ahead, but I Won't

The 2021 Tax Loss Selling Recovery Portfolio is killing it, which makes it tempting to shut it down and harvest the profits, but we'll let the experiment roll on.

The Week That Was, Upcoming FOMC Meeting, Bitcoin Regulation?, Watching AMD

The Week That Was, Upcoming FOMC Meeting, Bitcoin Regulation?, Watching AMD

Where there will be change with the FOMC will be in the economic projections, the first made since December.

My Tax Loss Selling Recovery Portfolio Is Impressive So Far

My Tax Loss Selling Recovery Portfolio Is Impressive So Far

But we're still in the early innings.

My Tax Loss Selling Recovery Portfolio Is Doing Better Than I Thought

My Tax Loss Selling Recovery Portfolio Is Doing Better Than I Thought

The rise in retail has been a tailwind for the portfolio.

Initial Returns of These 12 Losers From 2020 Aren't Spectacular but Are OK

Initial Returns of These 12 Losers From 2020 Aren't Spectacular but Are OK

There is one standout performer among this portfolio of a dozen stocks that struggled last year, but most haven't moved all that much after just a month.

Finally, the Final Four of My 2021 Tax-Loss Selling Recovery Portfolio

Finally, the Final Four of My 2021 Tax-Loss Selling Recovery Portfolio

AER, GIII, SBH, and PSXP make the cut.

It's Time to Reveal the First 4 Ugly Ducklings of This Deep-Value Portfolio

It's Time to Reveal the First 4 Ugly Ducklings of This Deep-Value Portfolio

A drugstore giant, a maker of office technology, a chicken producer and a shoe seller make up one-third of the 2021 Tax Loss Selling Recovery Portfolio.

Jim Cramer: Meet the Magnificent Seven

Jim Cramer: Meet the Magnificent Seven

It might be like cold water in the face to think that earnings don't matter. But these stocks have detached themselves from all metrics.

Xerox's Bid Has Been Good for HP Shareholders -- Even if HP Is Wise to Reject It

Xerox's Bid Has Been Good for HP Shareholders -- Even if HP Is Wise to Reject It

Among other things, HP has responded to Xerox's hostile bid by unveiling a $15 billion buyback program and signaling that it's open to other M&A transactions.

What About a Deal With HP Inc. and DocuSign?

What About a Deal With HP Inc. and DocuSign?

What boggles my mind is DocuSign sitting out there at $15 billion that could work well with HPQ - or Xerox - and their strong free cash flow.

HP Inc.? I'll Pass

HP Inc.? I'll Pass

I did look out three months to see if there was maybe an intelligent way to play this name through the options market.

HP and Dell's Earnings Call Comments Suggest Intel CPU Shortages Have Expanded

HP and Dell's Earnings Call Comments Suggest Intel CPU Shortages Have Expanded

The PC giants said they now expect Intel CPU shortages to continue into 2020, with Dell indicating costlier CPUs are now also affected. That could spell a bigger opening for AMD.

Don't Write Off the Possibility of DocuSign Getting Snapped Up

Don't Write Off the Possibility of DocuSign Getting Snapped Up

Xerox or HP or both should consider going after DOCU, and here are two ways for investors to do the same.

HP Has Plenty of Good Reasons for Rejecting Xerox's Initial Buyout Offer

HP Has Plenty of Good Reasons for Rejecting Xerox's Initial Buyout Offer

Though HP says it's still open to some kind of deal with Xerox, the deal that Xerox proposed would carry major financial risks on top of all the execution and revenue growth risks any kind of merger between the firms would carry.

HP and Xerox? Not Such a Bad Idea

HP and Xerox? Not Such a Bad Idea

With Carl Icahn involved on both sides, we can expect him to lean heavily on both Boards to come to an agreement.

HP Has My Attention, but I'm Not Getting In Now

HP Has My Attention, but I'm Not Getting In Now

If tempted, don't forget HPQ will report the firm's fourth quarter performance next Tuesday.

HP Plays Hard to Get, but Charts Provide a Clearer Picture

HP Plays Hard to Get, but Charts Provide a Clearer Picture

HP's board of directors has rejected Xerox's takeover bid, but the door has not been closed on a potential combination.

Xerox Raised to Neutral at JPMorgan

Jim Cramer: Want to Know Why We Keep Going Up? Look at Stocks

Jim Cramer: Want to Know Why We Keep Going Up? Look at Stocks

Everywhere I go I hear the smart money is betting on a recession, that earnings will be down, but every day something contradicts these bears.

Xerox Is Looking Attractive on the Charts: Copy That!

Xerox Is Looking Attractive on the Charts: Copy That!

Traders could go long XRX at current levels.

Xerox's Reported Bid for HP Has an Air of Desperation to It

Xerox's Reported Bid for HP Has an Air of Desperation to It

It's far from certain that Xerox can digest HP, and it would face plenty of challenges if it did. But with Xerox's core businesses continuing to decline, the company might be feeling desperate.

Jim Cramer: Stop Speculating on Deals

Jim Cramer: Stop Speculating on Deals

I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.

Why a Walgreens Buyout Could Stink for Corporate Bond Investors

Why a Walgreens Buyout Could Stink for Corporate Bond Investors

Reports of two potentially major buyouts show the risks of late-cycle corporate bond investing.

Xerox Cut at JP Morgan